View web version.
MJH Life Sciences

Looking for a way to leverage critical insights from pharmacists for your business?

Check out the data and insights from a recent virtual broadcast of ours, “Managing Multiple Sclerosis: Examining Oral Treatment Options and Specialty Considerations” held on May 10, 2021 during Asembia’s Specialty Summit.

544

participants

44%

work in managed care settings

62%

participating pharmacists reported being responsible for patients with specialty medications

14,136

interactions each year with patients who are receiving treatment for MS

103%

improvement in their knowledge of oral DMTs for the treatment of MS

The largest change pharmacists intend to implement is sharing with a peer the information learned.

Biggest barriers pharmacists are identifying - limited consultation time with patients during initiation of medication and follow-up

A note from our president:

 

“PTCE is excited to share the impact of this engaging and accessible session that resulted from our partnership with Asembia. As new data and clinical insights on the efficacy and safety of novel oral treatments for MS emerge, we remain committed to empowering pharmacists with practical information that they can apply to optimizing coordination of care for their patients.”

Jim Palatine, RPh, MBA
President, PTCE


Contact your Manager of Education for more information on how your company can capitalize on our virtual sessions.

 

Jim Palatine, RPh, MBA
President
Email Jim
O: 609.325.4809
C: 215.859.7351

Mackenzie Perry, PharmD
Manager of Education, Oncology
Email Mackenzie
O: 609.250.4337
C: 570.877.4050

Oliver Mills, PharmD
Manager of Education
Email Oliver
O: 609.250.4300
C: 618.670.1937

Meagan Brixie
Manager of Education
Email Meagan
O: 609.325.4903
C: 732.266.5552

Nicole Grassano
Manager of Education
Email Nicole
O: 609.325.4774
C: 732.539.0872

MJH Life Sciences